JP2023058660A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023058660A5 JP2023058660A5 JP2023020860A JP2023020860A JP2023058660A5 JP 2023058660 A5 JP2023058660 A5 JP 2023058660A5 JP 2023020860 A JP2023020860 A JP 2023020860A JP 2023020860 A JP2023020860 A JP 2023020860A JP 2023058660 A5 JP2023058660 A5 JP 2023058660A5
- Authority
- JP
- Japan
- Prior art keywords
- fibroblasts
- adm
- pharmaceutical composition
- hhex
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021034018 | 2021-03-04 | ||
| JP2021034018 | 2021-03-04 | ||
| JP2021034016 | 2021-03-04 | ||
| JP2021034016 | 2021-03-04 | ||
| JP2022539639A JP7233147B2 (ja) | 2021-03-04 | 2022-03-03 | リンパ管新生促進因子発現線維芽細胞及びそれを含む医薬組成物 |
| PCT/JP2022/009205 WO2022186349A1 (ja) | 2021-03-04 | 2022-03-03 | リンパ管新生促進因子発現線維芽細胞及びそれを含む医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539639A Division JP7233147B2 (ja) | 2021-03-04 | 2022-03-03 | リンパ管新生促進因子発現線維芽細胞及びそれを含む医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023058660A JP2023058660A (ja) | 2023-04-25 |
| JP2023058660A5 true JP2023058660A5 (https=) | 2025-03-06 |
Family
ID=83155368
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539639A Active JP7233147B2 (ja) | 2021-03-04 | 2022-03-03 | リンパ管新生促進因子発現線維芽細胞及びそれを含む医薬組成物 |
| JP2023020860A Withdrawn JP2023058660A (ja) | 2021-03-04 | 2023-02-14 | リンパ管新生促進因子発現線維芽細胞及びそれを含む医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539639A Active JP7233147B2 (ja) | 2021-03-04 | 2022-03-03 | リンパ管新生促進因子発現線維芽細胞及びそれを含む医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240148795A1 (https=) |
| EP (1) | EP4302771A4 (https=) |
| JP (2) | JP7233147B2 (https=) |
| KR (1) | KR20230154177A (https=) |
| AU (1) | AU2022231584A1 (https=) |
| CA (1) | CA3211113A1 (https=) |
| IL (1) | IL305069A (https=) |
| WO (1) | WO2022186349A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240316113A1 (en) * | 2021-09-08 | 2024-09-26 | Metcela Inc. | Fibroblast-containing pharmaceutical composition for treating kidney disease |
| JP2025515887A (ja) | 2022-11-11 | 2025-05-20 | エルジー エナジー ソリューション リミテッド | 負極活物質、これを含む負極、これを含む二次電池、および負極活物質の製造方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102407387B1 (ko) * | 2017-02-24 | 2022-06-10 | 가부시키가이샤 메토세라 | 섬유아세포를 포함하고, 심장 질환들의 치료를 위하여 사용될 수 있는 주사용 조성물, 및 치료 용도를 위하여 섬유아세포를 생산하는 방법 |
| EP3845635A4 (en) | 2018-08-29 | 2022-06-15 | Metcela Inc. | PROCEDURE FOR PREPARING FIBROBLAST AND G-CSF-POSITIVE FIBROBLAST MASS |
| US20240316113A1 (en) * | 2021-09-08 | 2024-09-26 | Metcela Inc. | Fibroblast-containing pharmaceutical composition for treating kidney disease |
-
2022
- 2022-03-03 CA CA3211113A patent/CA3211113A1/en active Pending
- 2022-03-03 AU AU2022231584A patent/AU2022231584A1/en active Pending
- 2022-03-03 KR KR1020237027718A patent/KR20230154177A/ko active Pending
- 2022-03-03 IL IL305069A patent/IL305069A/en unknown
- 2022-03-03 WO PCT/JP2022/009205 patent/WO2022186349A1/ja not_active Ceased
- 2022-03-03 EP EP22763401.1A patent/EP4302771A4/en active Pending
- 2022-03-03 JP JP2022539639A patent/JP7233147B2/ja active Active
- 2022-03-03 US US18/548,803 patent/US20240148795A1/en active Pending
-
2023
- 2023-02-14 JP JP2023020860A patent/JP2023058660A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023058660A5 (https=) | ||
| Friedman | Stellate cell activation in alcoholic fibrosi—an overview | |
| Sandvig et al. | Neuroplasticity in stroke recovery. The role of microglia in engaging and modifying synapses and networks | |
| Nakou et al. | Healthy aging and myocardium: A complicated process with various effects in cardiac structure and physiology | |
| Freund et al. | Upregulation of nerve growth factor expression by human airway smooth muscle cells in inflammatory conditions | |
| JPWO2022186349A5 (https=) | ||
| Miguel et al. | Enhanced fatty acid oxidation through metformin and baicalin as therapy for COVID-19 and associated inflammatory states in lung and kidney | |
| CA3095082A1 (en) | Combinations of osteopontin and 2'-fucosyllactose for use as medicaments | |
| Ramadass et al. | Type I collagen and its daughter peptides for targeting mucosal healing in ulcerative colitis: A new treatment strategy | |
| Kray et al. | Dual SMN inducing therapies can rescue survival and motor unit function in symptomatic∆ 7SMA mice | |
| JP2025536317A (ja) | 抗炎症効能があるラクチプランチバチルス・プランタラムｋｍ２菌株の発酵培養上澄み液のマイクロバイオーム組成物 | |
| Chen et al. | Effects of 1, 25-dihydroxyvitamin D3 in an ovalbumin-induced allergic rhinitis model | |
| Li et al. | Microglia in Post‐Traumatic Brain Injury (TBI) Cognitive Impairment: From Pathological Changes to Therapeutic Approaches | |
| Usmanov et al. | Emerging trends in the use of therapeutic hypothermia as a method for neuroprotection in brain damage | |
| Shin et al. | Effects of fungi and eosinophils on mucin gene expression in rhinovirus-infected nasal epithelial cells | |
| Guzmán et al. | Human Diseases and Recent Biotechnology Breakthroughs in Curbing Diseases | |
| Ciprandi et al. | Comano thermal water inhalations in the treatment of allergic rhinitis: preliminary results | |
| JP2023548220A (ja) | 単離されたミトコンドリアを含む、線維症を予防又は治療するための医薬組成物 | |
| CN118873667A (zh) | Lat1抑制剂在制备治疗动脉粥样硬化的药物中的应用 | |
| JP2016508036A5 (https=) | ||
| Farooq et al. | A Recent Update on the Role of Nutraceuticals in COVID-19 Infection | |
| CN114028572B (zh) | Mat2a抑制剂用于治疗哮喘的新应用 | |
| Hu et al. | Neuroprotective effects of phenylacetylglycine via β2AR on cerebral ischemia/reperfusion injury in rats | |
| WO2023178338A3 (en) | Methods and compositions for treating tmem43 related cardiomyopathy with a viral vector | |
| Zaenker | Infection, inflammation and neoplasia: an interdisciplinary challenge |